Picture EBD Group Bio-Europe Spring 2024 Barcelona 650x100px
Document › Details

Bruker Corporation. (2/25/19). "Press Release: Bruker Corporation to Present at Investor Conferences". Billerica, MA.

Organisations Organisation Bruker Corporation (Nasdaq: BRKR)
  Group Bruker (Group)
  Organisation 2 Cowen & Company LLC
Products Product SVB Leerink Annual Global Healthcare Conference 2019 New York
  Product 2 Cowen & Co. Annual Health Care Conference 2019 Boston
Index terms Index term Bruker–SVB: investor conference, 201902 supply service Bruker presents at SVB Leerink Global Healthcare Conference
  Index term 2 Bruker–Barclays: investor conference, 201903 supply service Bruker presents at Barclays Global Healthcare Conference
Persons Person Laukien, Frank H. (Bruker 201204 President + CEO)
  Person 2 Herman, Gerald N. (Bruker Corp 201806– CFO before Interim CFO joined 12/16 as VP + Corp Controller before Parexel)

Bruker Corporation (Nasdaq: BRKR) announced today it will present at the following conferences:

8th Annual SVB Leerink Healthcare Conference, New York, NY
Thursday, February 28, 2019, at 10:30 a.m. Eastern Time
Frank Laukien, Chairman, President and Chief Executive Officer

Cowen 39th Annual Health Care Conference, Boston, MA
Tuesday, March 12, 2019, at 10:40 a.m. Eastern Time
Gerald Herman, Chief Financial Officer

Barclays Global Healthcare Conference, Miami Beach, FL
Thursday, March 14, 2019, at 10:45 a.m. Eastern Time
Frank Laukien, Chairman, President and Chief Executive Officer

Live audio webcasts of the presentations will be available on the Investor Relations section of the Company's website at Replays will be posted on the Bruker Corporation Investor Relations website after each event and will be available for 30 days following the presentation.

About Bruker Corporation (Nasdaq: BRKR)

Bruker is enabling scientists to make breakthrough discoveries and develop new applications that improve the quality of human life. Bruker's high-performance scientific instruments and high-value analytical and diagnostic solutions enable scientists to explore life and materials at molecular, cellular and microscopic levels. In close cooperation with our customers, Bruker is enabling innovation, improved productivity and customer success in life science molecular research, in applied and pharma applications, in microscopy and nanoanalysis, and in industrial applications, as well as in cell biology, preclinical imaging, clinical phenomics and proteomics research and clinical microbiology. For more information, please visit:

Contact :

Miroslava Minkova
Director, Investor Relations & Corporate Development
Bruker Corporation
T: +1 (978) 663 – 3660, ext. 1479

Record changed: 2023-06-05


Picture Consultech GmbH Secure Funding with RnD Grants 650x200px

More documents for Bruker (Group)

To subscribe to our free, monthly mass spectrometry newsletter, please send an e-mail to and simply fill the subject line with the word »MSC Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the Eurpean life sciences and the life sciences in German-speaking Europe (DE, AT & CH) at and


Picture EBD Group Asia Bio Partnering Forum 2024 Singapore 650x300px

» top